Work

A phase I window, dose escalating and safety trial of metformin in combination with induction chemotherapy in relapsed refractory acute lymphoblastic leukemia: Metformin with induction chemotherapy of vincristine, dexamethasone, doxorubicin, and PEG-asparaginase (VPLD).

Year: 2016

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2016.34.15_suppl.10530

Authors: Julio C. Barredo, John M. Goldberg, Gregory Hale, Jonathan Benjamin Gill, Bhuvana Setty, Tiffany Smith, Jae K Lee, Damon R. Reed

Institutions: University of Miami, Johns Hopkins All Children's Hospital, Children's Hospital at Montefiore, Nationwide Children's Hospital, The Ohio State University, Moffitt Cancer Center

Language: English

Topic: Acute Lymphoblastic Leukemia research

Subfield: Public Health, Environmental and Occupational Health

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2474957073

Cites:

Cited by:

Related to: 10